Stock Market News Stock Market News
  • Dow
  • S&P
  • Nasdaq
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Crypto
  • Forex
  • Tech
  • Politics
  • +

2 days Amphastar Pharmaceuticals: Cheap With Caveats Seeking Alpha

Amphastar Pharmaceuticals: Cheap With Caveats.

Pharmaceuticals

  X     

2 days Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Moves to Buy: Rationale Behind the Upgrade Zacks

   X     

3 days Jefferies starts Rhythm Pharmaceuticals with Buy on obesity potential Yahoo Finance

   X     

3 days Crinetics Pharmaceuticals: Attractive Speculative Bet On Market Weakness Seeking Alpha

   X     

4 days Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report? Zacks

   X     

4 days Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year? Zacks

   X     

4 days Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

4 days Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? Zacks

   X     

5 days Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors Zacks

   X     

5 days Here’s Why Acadia Pharmaceuticals (ACAD) is a Strong Momentum Stock Zacks

   X     

5 days Vertex Pharmaceuticals: Jim Cramer Fires A Warning Shot But I Remain Invested Seeking Alpha

   X     

5 days Wedbush starts Rocket Pharmaceuticals with Outperform into ‘inflection year’ Yahoo Finance

   X     

5 days Marinus Pharmaceuticals to be acquired by Immedica for 55c per share Yahoo Finance

   X     

5 days Citius Pharmaceuticals upgraded to Buy from Hold at D. Boral Capital Yahoo Finance

   X     

6 days Centessa Pharmaceuticals: Orexin Franchise Worth Monitoring Seeking Alpha

   X     

6 days Rigel Pharmaceuticals: Realizing The Promise Of Its Acquired Pipeline Agents Seeking Alpha

   X     

6 days Is the Options Market Predicting a Spike in Vertex Pharmaceuticals (VRTX) Stock? Zacks

   X     

1 week Elite Pharmaceuticals Launches Generic Vyvanse for ADHD Market Yahoo Finance

   X     

1 week Telix Pharmaceuticals: Australian Company And A Solid Recent U.S. IPO Seeking Alpha

   X     

1 week All You Need to Know About ANI (ANIP) Rating Upgrade to Buy Zacks

   X     

1 week How Tarsus Pharmaceuticals’ Unique Inspiration Is Driving A Triple-Digit Run Investor's Business Daily

   X     

1 week The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex Zacks

   X     

1 week The Zacks Analyst Blog Highlights T-Mobile, Toyota Motor, Vertex Pharmaceuticals, BK Technologies and Servotronics Zacks

   X     

2 weeks NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here’s Why Zacks

   X     

2 weeks Mirum Pharmaceuticals: Buy At Dips For Volixibat Potential Seeking Alpha

   X     

2 weeks Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year? Zacks

   X     

2 weeks Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know Zacks

   X     

2 weeks Top Stock Reports for T-Mobile, Toyota Motor & Vertex Pharmaceuticals Zacks

   X     

2 weeks Vertex Pharmaceuticals price target lowered to $460 from $550 at Truist Yahoo Finance

   X     

2 weeks Anebulo Pharmaceuticals collaborates with FDA to advance selonabant Yahoo Finance

   X     

2 weeks Vertex Secures FDA Approval for New Cystic Fibrosis Drug Alyftrek Zacks

   X     

2 weeks Jazz Pharmaceuticals: Should Sing A Better Tune In 2025 Seeking Alpha

   X     

2 weeks Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last? Zacks

   X     

2 weeks Ionis Pharmaceuticals: Promising Growth From Tryngolza Approval Seeking Alpha

   X     

2 weeks Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Zacks

   X     

2 weeks Is Recursion Pharmaceuticals Stock a Millionaire Maker? Yahoo Finance

   X     

2 weeks Vertex Pharmaceuticals price target lowered to $441 from $506 at Bernstein Yahoo Finance

   X     

2 weeks Vertex Wins An Early Approval; Why It Might Not Move Vertex’s Beleaguered Stock Investor's Business Daily

   X     

2 weeks Ironwood Pharmaceuticals shares surge on competitor’s woes Investing.com

   X     

2 weeks Rhythm Pharmaceuticals’ Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential Yahoo Finance

   X     

2 weeks Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity Seeking Alpha

   X     

2 weeks VRTX Down as Non-Opioid Drug Shows Similar Pain Reduction as Placebo Zacks

   X     

2 weeks Cramer’s Mad Dash: Vertex Pharmaceuticals YouTube

   X     

2 weeks Ionis Gets FDA Approval for Rare Disease Drug Tryngolza Zacks

   X     

2 weeks Cramer’s Stop Trading: Vertex Pharmaceuticals YouTube

   X     

2 weeks Vertex Non-Opioid Drug Doesn’t Best Placebo In Back Pain Study. The Stock Is Plunging. Investor's Business Daily

   X     

3 weeks Corvus Pharmaceuticals: Not Just A One-Hit Wonder In ITK Inhibitor Targeting Seeking Alpha

   X     

3 weeks REGN’s Eylea HD Shows Non-Inferiority to Eylea in Eye Disease Study Zacks

   X     

3 weeks Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? Zacks

   X     

3 weeks Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It Zacks

   X     

3 weeks SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study Zacks

   X     
More news +
Home | Contact
  • X

© 2025 The Stock Market News